
LOCUS       NM_000016               1317 bp    mRNA    linear   PRI 09-APR-2017
DEFINITION  Homo sapiens N-acetyltransferase 2 (NAT2), mRNA.
ACCESSION   NM_000015
VERSION     NM_000016.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 1317)
  AUTHORS   Ma C, Gu L, Yang M, Zhang Z, Zeng S, Song R, Xu C and Sun Y.
  TITLE     rs1495741 as a tag single nucleotide polymorphism of
            N-acetyltransferase 2 acetylator phenotype associates bladder
            cancer risk and interacts with smoking: A systematic review and
            meta-analysis
  JOURNAL   Medicine (Baltimore) 95 (31), E4417 (2016)
   PUBMED   27495060
  REMARK    GeneRIF: NAT2 single nucleotide polymorphism associated with the
            risk bladder cancer development and interacts with smoking.
            Review article
REFERENCE   2  (bases 1 to 1317)
  AUTHORS   Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E and Agundez
            JA.
  TITLE     NAT2 polymorphisms and risk for Parkinson's disease: a systematic
            review and meta-analysis
  JOURNAL   Expert Opin Drug Metab Toxicol 12 (8), 937-946 (2016)
   PUBMED   27216438
  REMARK    GeneRIF: Data on NAT2 gene polymorphisms obtained from the current
            meta-analysis do not support a major association with Parkinson's
            diease risk, except in Asian populations
            Review article
REFERENCE   3  (bases 1 to 1317)
  AUTHORS   Suarez-Kurtz G, Fuchshuber-Moraes M, Struchiner CJ and Parra EJ.
  TITLE     Single nucleotide polymorphism coverage and inference of
            N-acetyltransferase-2 acetylator phenotypes in wordwide population
            groups
  JOURNAL   Pharmacogenet. Genomics 26 (8), 363-369 (2016)
   PUBMED   27136043
  REMARK    GeneRIF: Single nucleotide polymorphism is associated with
            different N-acetyltransferase-2 acetylator phenotypes in wordwide
            population groups.
REFERENCE   4  (bases 1 to 1317)
  AUTHORS   Chamorro JG, Castagnino JP, Musella RM, Nogueras M, Frias A, Visca
            M, Aidar O, Costa L and de Larranaga GF.
  TITLE     tagSNP rs1495741 as a useful molecular marker to predict
            antituberculosis drug-induced hepatotoxicity
  JOURNAL   Pharmacogenet. Genomics 26 (7), 357-361 (2016)
   PUBMED   27104815
  REMARK    GeneRIF: NAT2 gene variants were associated with antituberculosis
            drug-induced hepatotoxicity.
REFERENCE   5  (bases 1 to 1317)
  AUTHORS   Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans DA, Grant DM, Hein
            DW, Lin HJ, Meyer UA, Relling MV et al.
  TITLE     Nomenclature for N-acetyltransferases
  JOURNAL   Pharmacogenetics 5 (1), 1-17 (1995)
   PUBMED   7773298
  REMARK    Review article
REFERENCE   6  (bases 1 to 1317)
  AUTHORS   Hickman D, Risch A, Camilleri JP and Sim E.
  TITLE     Genotyping human polymorphic arylamine N-acetyltransferase:
            identification of new slow allotypic variants
  JOURNAL   Pharmacogenetics 2 (5), 217-226 (1992)
   PUBMED   1306121
REFERENCE   7  (bases 1 to 1317)
  AUTHORS   Deguchi T.
  TITLE     Sequences and expression of alleles of polymorphic arylamine
            N-acetyltransferase of human liver
  JOURNAL   J. Biol. Chem. 267 (25), 18140-18147 (1992)
   PUBMED   1381364
REFERENCE   8  (bases 1 to 1317)
  AUTHORS   Grant DM, Blum M and Meyer UA.
  TITLE     Polymorphisms of N-acetyltransferase genes
  JOURNAL   Xenobiotica 22 (9-10), 1073-1081 (1992)
   PUBMED   1441598
REFERENCE   9  (bases 1 to 1317)
  AUTHORS   Blum M, Grant DM, McBride W, Heim M and Meyer UA.
  TITLE     Human arylamine N-acetyltransferase genes: isolation, chromosomal
            localization, and functional expression
  JOURNAL   DNA Cell Biol. 9 (3), 193-203 (1990)
   PUBMED   2340091
REFERENCE   10 (bases 1 to 1317)
  AUTHORS   Grant DM, Lottspeich F and Meyer UA.
  TITLE     Evidence for two closely related isozymes of arylamine
            N-acetyltransferase in human liver
  JOURNAL   FEBS Lett. 244 (1), 203-207 (1989)
   PUBMED   2924904
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC025062.6, D90042.1 and
            AI460128.1.
            This sequence is a reference standard in the RefSeqGene project.
            
            Summary: This gene encodes an enzyme that functions to both
            activate and deactivate arylamine and hydrazine drugs and
            carcinogens. Polymorphisms in this gene are responsible for the
            N-acetylation polymorphism in which human populations segregate
            into rapid, intermediate, and slow acetylator phenotypes.
            Polymorphisms in this gene are also associated with higher
            incidences of cancer and drug toxicity. A second arylamine
            N-acetyltransferase gene (NAT1) is located near this gene (NAT2).
            [provided by RefSeq, Jul 2008].
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: D90042.1, BC067218.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA1966682, SAMEA1968540
                                           [ECO:0000348]
            ##Evidence-Data-END##
            COMPLETENESS: complete on the 3' end.
FEATURES             Location/Qualifiers
     source          1..1317
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="8"
                     /map="8p22"
     gene            1..1317
                     /gene="NAT2"
                     /gene_synonym="AAC2; NAT-2; PNAT"
                     /note="N-acetyltransferase 2"
                     /db_xref="GeneID:10"
                     /db_xref="HGNC:HGNC:7646"
                     /db_xref="MIM:612182"
     CDS             108..980
                     /gene="NAT2"
                     /gene_synonym="AAC2; NAT-2; PNAT"
                     /EC_number="2.3.1.5"
                     /note="arylamide acetylase 2; N-acetyltransferase 2
                     (arylamine N-acetyltransferase); N-acetyltransferase type
                     2"
                     /codon_start=1
                     /product="arylamine N-acetyltransferase 2"
                     /protein_id="NP_000006.2"
                     /db_xref="CCDS:CCDS6008.1"
                     /db_xref="GeneID:10"
                     /db_xref="HGNC:HGNC:7646"
                     /db_xref="MIM:612182"
                     /translation="MDIEAYFERIGYKNSRNKLDLETLTDILEHQIRAVPFENLNMHC
                     GQAMELGLEAIFDHIVRRNRGGWCLQVNQLLYWALTTIGFQTTMLGGYFYIPPVNKYS
                     TGMVHLLLQVTIDGRNYIVDAGSGSSSQMWQPLELISGKDQPQVPCIFCLTEERGIWY
                     LDQIRREQYITNKEFLNSHLLPKKKHQKIYLFTLEPRTIEDFESMNTYLQTSPTSSFI
                     TTSFCSLQTPEGVYCLVGFILTYRKFNYKDNTDLVEFKTLTEEEVEEVLRNIFKISLG
                     RNLVPKPGDGSLTI"
     misc_feature    423..428
                     /gene="NAT2"
                     /gene_synonym="AAC2; NAT-2; PNAT"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P11245.1);
                     Region: Substrate binding. {ECO:0000305}"
     regulatory      1301..1306
                     /regulatory_class="polyA_signal_sequence"
                     /gene="NAT2"
                     /gene_synonym="AAC2; NAT-2; PNAT"
BASE COUNT      418 a    252 c    263 g    384 t
ORIGIN      
        1 tgagatcact tcccttgcag actttggaag ggagagcact ttattacaga ccttggaagc
       61 aagaggattg cattcagcct agttcctggt tgctggccaa agggatcatg gacattgaag
      121 catattttga aagaattggc tataagaact ctaggaacaa attggacttg gaaacattaa
      181 ctgacattct tgagcaccag atccgggctg ttccctttga gaaccttaac atgcattgtg
      241 ggcaagccat ggagttgggc ttagaggcta tttttgatca cattgtaaga agaaaccggg
      301 gtgggtggtg tctccaggtc aatcaacttc tgtactgggc tctgaccaca atcggttttc
      361 agaccacaat gttaggaggg tatttttaca tccctccagt taacaaatac agcactggca
      421 tggttcacct tctcctgcag gtgaccattg acggcaggaa ttacattgtc gatgctgggt
      481 ctggaagctc ctcccagatg tggcagcctc tagaattaat ttctgggaag gatcagcctc
      541 aggtgccttg cattttctgc ttgacagaag agagaggaat ctggtacctg gaccaaatca
      601 ggagagagca gtatattaca aacaaagaat ttcttaattc tcatctcctg ccaaagaaga
      661 aacaccaaaa aatatactta tttacgcttg aacctcgaac aattgaagat tttgagtcta
      721 tgaatacata cctgcagacg tctccaacat cttcatttat aaccacatca ttttgttcct
      781 tgcagacccc agaaggggtt tactgtttgg tgggcttcat cctcacctat agaaaattca
      841 attataaaga caatacagat ctggtcgagt ttaaaactct cactgaggaa gaggttgaag
      901 aagtgctgag aaatatattt aagatttcct tggggagaaa tctcgtgccc aaacctggtg
      961 atggatccct tactatttag aataaggaac aaaataaacc cttgtgtatg tatcacccaa
     1021 ctcactaatt atcaacttat gtgctatcag atatcctctc taccctcacg ttattttgaa
     1081 gaaaatccta aacatcaaat actttcatcc ataaaaatgt cagcatttat taaaaaacaa
     1141 taacttttta aagaaacata aggacacatt ttcaaattaa taaaaataaa ggcattttaa
     1201 ggatggcctg tgattatctt gggaagcaga gtgattcatg ctagaaaaca tttaatattg
     1261 atttattgtt gaattcatag taaattttta ctggtaaatg aataaagaat attgtgg
//
